Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 15, 2026
Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report.
Journal: Clinical genitourinary cancer
Published: May 09, 2026
Renal function outcomes following endoscopic management of upper tract urothelial carcinoma.
Journal: World journal of urology
Published: April 02, 2026
Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinoma.
Journal: World journal of urology
Published: March 27, 2026
Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel.
Journal: The Journal of urology
Published: November 19, 2024
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer.
Journal: The Journal of clinical investigation
Published: September 06, 2024
Durability of response of UGN-101: Longitudinal follow up of multicenter study.
Journal: Urologic oncology
Published: September 02, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 16, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
Journal: The Lancet. Oncology
Published: January 15, 2024
Last Updated: 09/26/2026